CoreCap Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.5K Buy
439
+3
+0.7% +$282 ﹤0.01% 1614
2026
Q1
$51.6K Sell
436
-86
-16% -$10.6K ﹤0.01% 1298
2025
Q4
$65.6K Sell
522
-61
-10% -$7.96K ﹤0.01% 1202
2025
Q3
$85.4K Sell
583
-122
-17% -$18.4K ﹤0.01% 1097
2025
Q2
$110K Sell
705
-58
-8% -$9.2K ﹤0.01% 950
2025
Q1
$126K Sell
763
-287
-27% -$47.7K 0.01% 825
2024
Q4
$171K Buy
1,050
+125
+14% +$22.4K 0.01% 743
2024
Q3
$181K Sell
925
-40
-4% -$7.37K 0.01% 726
2024
Q2
$167K Buy
965
+55
+6% +$9.15K 0.02% 394
2024
Q1
$154K Buy
+910
New +$170K 0.01% 697
2022
Q4
$105K Buy
+716
New +$106K 0.01% 718
2022
Q3
Sell
-680
Closed -$117K 2161
2022
Q2
$117K Buy
+680
New +$118K 0.01% 641
2022
Q1
Sell
-1,603
Closed -$391K 2159
2021
Q4
$391K Buy
+1,603
New +$351K 0.03% 402

Other funds holding ZTS

CoreCap Advisors's ZTS Position: Q2 2026 in Review

CoreCap Advisors increased its Zoetis (ZTS) stake by 0.69% in Q2 2026, buying an estimated $282 and bringing the position to 439 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1614.

CoreCap Advisors first reported a position in ZTS in Q4 2021 and has held it in 13 quarters since. The position peaked at $391K in Q4 2021. 274 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • CoreCap Advisors held 439 shares of Zoetis worth $31.5K as of Q2 2026.
  • CoreCap Advisors bought 3 Zoetis shares in Q2 2026, an estimated $282.
  • Zoetis made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1614 holding.
  • CoreCap Advisors first reported a position in Zoetis in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's Zoetis position peaked at $391K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.